EP2844271 - USE OF FOLLISTATIN OR OF AN ACTIVIN INHIBITOR FOR PREVENTING OR TREATING TISSUE GRAFT DYSFUNCTION [Right-click to bookmark this link] | |||
Former [2015/11] | A METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME | ||
[2017/37] | Status | No opposition filed within time limit Status updated on 04.01.2019 Database last updated on 03.09.2024 | |
Former | The patent has been granted Status updated on 26.01.2018 | ||
Former | Grant of patent is intended Status updated on 19.01.2018 | ||
Former | Examination is in progress Status updated on 03.01.2018 | ||
Former | Grant of patent is intended Status updated on 31.08.2017 | ||
Former | Examination is in progress Status updated on 03.02.2017 | Most recent event Tooltip | 10.07.2020 | Lapse of the patent in a contracting state New state(s): IS | published on 12.08.2020 [2020/33] | Applicant(s) | For all designated states Paranta Biosciences Limited 189-191 Balaclava Road Caulfield VIC 3161 / AU | [2015/11] | Inventor(s) | 01 /
DE KRETSER, David 1 Leura Street Surrey Hills, Victoria 3127 / AU | 02 /
O'HEHIR, Robyn 120 Gatehouse Street Parkville, Victoria 3052 / AU | [2015/51] |
Former [2015/11] | 01 /
DE KRETSER, David 1 Leura Street Surrey Hills, Victoria 3127 / AU | ||
02 /
O'HEHIR, Robyn 120 Gatehouse Street Parkville, Victoria 3052 / AU | |||
03 /
CHEN, Yi 41 Seaview Avenue Bentleigh, Victoria 3204 / AU | Representative(s) | Weickmann & Weickmann PartmbB Postfach 860 820 81635 München / DE | [2018/09] |
Former [2015/11] | Weickmann, Hans, et al Weickmann & Weickmann Postfach 860 820 81635 München / DE | Application number, filing date | 13791008.9 | 17.05.2013 | [2018/09] | WO2013AU00520 | Priority number, date | AU20120902036 | 17.05.2012 Original published format: AU 2012902036 | AU20120905402 | 11.12.2012 Original published format: AU 2012905402 | [2015/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013170315 | Date: | 21.11.2013 | Language: | EN | [2013/47] | Type: | A1 Application with search report | No.: | EP2844271 | Date: | 11.03.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.11.2013 takes the place of the publication of the European patent application. | [2015/11] | Type: | B1 Patent specification | No.: | EP2844271 | Date: | 28.02.2018 | Language: | EN | [2018/09] | Search report(s) | International search report - published on: | AU | 21.11.2013 | (Supplementary) European search report - dispatched on: | EP | 09.10.2015 | Classification | IPC: | A61K38/17, A61K38/22, A61K38/58, C07K14/575, A61K35/12, A61P37/06 | [2017/37] | CPC: |
A61K38/22 (EP,US);
A61K38/1709 (EP,US);
A61K38/1796 (EP,US);
A61K38/55 (EP,US);
A61K38/58 (EP,US);
A61P37/06 (EP);
| C-Set: |
A61K35/12, A61K2300/00 (EP,US)
|
Former IPC [2015/45] | A61K38/17, A61P37/06, A61K35/12, C07K14/47, A61K41/00 | ||
Former IPC [2015/11] | A61K38/17, A61P37/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/11] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | VERWENDUNG VON FOLLISTATIN ODER ACTIVIN INHIBITOREN ZUR PROPHYLAXIS ODER THERAPIE EINER GEWEBETRANSPLANTATSDYSFUNKTION | [2017/37] | English: | USE OF FOLLISTATIN OR OF AN ACTIVIN INHIBITOR FOR PREVENTING OR TREATING TISSUE GRAFT DYSFUNCTION | [2017/37] | French: | UTILISATION DE LA FOLLISTATINE OU D'UN INHIBITEUR DE L'ACTIVINE POUR PRÉVENIR OU TRAITER LE DYSFONCTIONNEMENT D'UNE GREFFE TISSULAIRE | [2017/37] |
Former [2015/11] | BEHANDLUNGSVERFAHREN UND MITTEL DAFÜR | ||
Former [2015/11] | A METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME | ||
Former [2015/11] | PROCÉDÉ DE TRAITEMENT ET AGENTS UTILES POUR CELUI-CI | Entry into regional phase | 10.09.2014 | National basic fee paid | 10.09.2014 | Search fee paid | 10.09.2014 | Designation fee(s) paid | 10.09.2014 | Examination fee paid | Examination procedure | 10.09.2014 | Examination requested [2015/11] | 21.06.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 28.07.2016 | Amendment by applicant (claims and/or description) | 07.02.2017 | Despatch of a communication from the examining division (Time limit: M04) | 06.06.2017 | Reply to a communication from the examining division | 01.09.2017 | Communication of intention to grant the patent | 02.01.2018 | Fee for grant paid | 02.01.2018 | Fee for publishing/printing paid | 03.01.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 18.01.2018 | Information about intention to grant a patent | 18.01.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.02.2017 | Opposition(s) | 29.11.2018 | No opposition filed within time limit [2019/06] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 28.07.2016 | Request for further processing filed | 28.07.2016 | Full payment received (date of receipt of payment) Request granted | 09.08.2016 | Decision despatched | Fees paid | Renewal fee | 12.05.2015 | Renewal fee patent year 03 | 10.05.2016 | Renewal fee patent year 04 | 24.04.2017 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 17.05.2013 | AL | 28.02.2018 | AT | 28.02.2018 | CY | 28.02.2018 | CZ | 28.02.2018 | DK | 28.02.2018 | EE | 28.02.2018 | FI | 28.02.2018 | HR | 28.02.2018 | LT | 28.02.2018 | LV | 28.02.2018 | MC | 28.02.2018 | MK | 28.02.2018 | NL | 28.02.2018 | PL | 28.02.2018 | PT | 28.02.2018 | RO | 28.02.2018 | RS | 28.02.2018 | SE | 28.02.2018 | SI | 28.02.2018 | SK | 28.02.2018 | SM | 28.02.2018 | TR | 28.02.2018 | IE | 17.05.2018 | LU | 17.05.2018 | MT | 17.05.2018 | BG | 28.05.2018 | NO | 28.05.2018 | GR | 29.05.2018 | BE | 31.05.2018 | CH | 31.05.2018 | LI | 31.05.2018 | IS | 28.06.2018 | [2020/33] |
Former [2020/31] | HU | 17.05.2013 | |
AL | 28.02.2018 | ||
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
DK | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
MC | 28.02.2018 | ||
MK | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
PT | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SI | 28.02.2018 | ||
SK | 28.02.2018 | ||
SM | 28.02.2018 | ||
TR | 28.02.2018 | ||
IE | 17.05.2018 | ||
LU | 17.05.2018 | ||
MT | 17.05.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
BE | 31.05.2018 | ||
CH | 31.05.2018 | ||
LI | 31.05.2018 | ||
Former [2020/28] | HU | 17.05.2013 | |
AL | 28.02.2018 | ||
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
DK | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
MC | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
PT | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SI | 28.02.2018 | ||
SK | 28.02.2018 | ||
SM | 28.02.2018 | ||
TR | 28.02.2018 | ||
IE | 17.05.2018 | ||
LU | 17.05.2018 | ||
MT | 17.05.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
BE | 31.05.2018 | ||
CH | 31.05.2018 | ||
LI | 31.05.2018 | ||
Former [2020/16] | AL | 28.02.2018 | |
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
DK | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
MC | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SI | 28.02.2018 | ||
SK | 28.02.2018 | ||
SM | 28.02.2018 | ||
TR | 28.02.2018 | ||
IE | 17.05.2018 | ||
LU | 17.05.2018 | ||
MT | 17.05.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
BE | 31.05.2018 | ||
CH | 31.05.2018 | ||
LI | 31.05.2018 | ||
Former [2020/08] | AL | 28.02.2018 | |
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
DK | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
MC | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SI | 28.02.2018 | ||
SK | 28.02.2018 | ||
SM | 28.02.2018 | ||
IE | 17.05.2018 | ||
LU | 17.05.2018 | ||
MT | 17.05.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
BE | 31.05.2018 | ||
CH | 31.05.2018 | ||
LI | 31.05.2018 | ||
Former [2019/24] | AL | 28.02.2018 | |
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
DK | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
MC | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SI | 28.02.2018 | ||
SK | 28.02.2018 | ||
SM | 28.02.2018 | ||
IE | 17.05.2018 | ||
LU | 17.05.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
BE | 31.05.2018 | ||
CH | 31.05.2018 | ||
LI | 31.05.2018 | ||
Former [2019/19] | AL | 28.02.2018 | |
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
DK | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
MC | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SI | 28.02.2018 | ||
SK | 28.02.2018 | ||
SM | 28.02.2018 | ||
IE | 17.05.2018 | ||
LU | 17.05.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
CH | 31.05.2018 | ||
LI | 31.05.2018 | ||
Former [2019/17] | AL | 28.02.2018 | |
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
DK | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
MC | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SI | 28.02.2018 | ||
SK | 28.02.2018 | ||
SM | 28.02.2018 | ||
LU | 17.05.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
CH | 31.05.2018 | ||
LI | 31.05.2018 | ||
Former [2019/12] | AL | 28.02.2018 | |
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
DK | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
MC | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SI | 28.02.2018 | ||
SK | 28.02.2018 | ||
SM | 28.02.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
CH | 31.05.2018 | ||
LI | 31.05.2018 | ||
Former [2019/06] | AL | 28.02.2018 | |
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
DK | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
MC | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SK | 28.02.2018 | ||
SM | 28.02.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
Former [2018/52] | AL | 28.02.2018 | |
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
DK | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SK | 28.02.2018 | ||
SM | 28.02.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
Former [2018/51] | AL | 28.02.2018 | |
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
DK | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SK | 28.02.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
Former [2018/50] | AL | 28.02.2018 | |
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
CZ | 28.02.2018 | ||
EE | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
NL | 28.02.2018 | ||
PL | 28.02.2018 | ||
RO | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
SK | 28.02.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
Former [2018/46] | AL | 28.02.2018 | |
AT | 28.02.2018 | ||
CY | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
NL | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
Former [2018/40] | AT | 28.02.2018 | |
CY | 28.02.2018 | ||
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
LV | 28.02.2018 | ||
NL | 28.02.2018 | ||
RS | 28.02.2018 | ||
SE | 28.02.2018 | ||
BG | 28.05.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
Former [2018/37] | CY | 28.02.2018 | |
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
NL | 28.02.2018 | ||
NO | 28.05.2018 | ||
GR | 29.05.2018 | ||
Former [2018/35] | CY | 28.02.2018 | |
FI | 28.02.2018 | ||
HR | 28.02.2018 | ||
LT | 28.02.2018 | ||
NL | 28.02.2018 | ||
NO | 28.05.2018 | Documents cited: | Search | [Y]US2002028762 (KOJIMA ITARU [JP]) [Y] 1-15* see claims and ex.3 *; | [XP] - FAKHFAKH RAOUIA ET AL, "Administration of a Soluble Activin Type IIB Receptor Promotes the Transplantation of Human Myoblasts in Dystrophic Mice", CELL TRANSPLANTATION, (20120630), vol. 21, no. 7, pages 1419 - 1430, XP002745054 [XP] 1,2,5,6,14 * see abstract, pages 1426-1427 * DOI: http://dx.doi.org/10.3727/096368911X627480 | [Y] - KANAMOTO MAMI ET AL, "Beneficial Effects of Follistatin in Hepatic Ischemia-Reperfusion Injuries in Rats", DIGESTIVE DISEASES AND SCIENCES, (201104), vol. 56, no. 4, pages 1075 - 1081, XP002745055 [Y] 1-15 * see abstract, p.1075 right col., p.1080 left col. * DOI: http://dx.doi.org/10.1007/s10620-010-1401-4 | International search | [X]WO02080952 (LORANTIS LTD [GB], et al); | [X]WO2004022730 (LORANTIS LTD [GB], et al); | [X]WO2005032578 (UNIV MONASH [AU], et al); | [X]US2008181869 (DEVORE DIANNA LOUISE [US]); | [X] - EL-AGGAN, H. A. ET AL., "STUDY OF SERUM ACTIVIN A AND FOLLISTATIN IN POST RENAL TRANSPLANT PATIENTS: CORRELATION WITH RENAL HEMODYNAMICS, GRAFT FUNCTION AND SURVIVAL", BUL. ALEX. FAC. MED., (2008), vol. 44, no. 4, pages 699 - 707, XP055161702 | by applicant | US5753187 | US5763263 | - BUNIN ET AL., PROC NATL ACAD SCI USA, (1994), vol. 91, pages 4708 - 4712 | - DEWITT ET AL., PROC NATL A CAD SCI USA, (1993), vol. 90, pages 6909 - 6913 | - ELBASHIR ET AL., METHODS, (2000), vol. 26, pages 199 - 213 | - DING, NUCL ACIDS RES, vol. 32, pages W135 - W141 | - DING; LAWRENCE, NUCL ACIDS RES, (2003), vol. 31, pages 7280 - 7301 | - DING; LAWRENCE, NUCL ACIDS RES, (2001), vol. 20, pages 1034 - 1046 | - EGLETON; DAVIS, PEPTIDES, (1997), pages 1431 - 1439 | - LANGER, SCIENCE, (1990), vol. 249, pages 1527 - 1533 |